#Investor Conferences #Ireland #Dublin #Jazz Pharmaceuticals #Fireside Chats

Jazz Pharmaceuticals' Upcoming Investor Conferences

Jazz Pharmaceuticals plc, a global biopharmaceutical company known for its commitment to developing life-changing medicines, has recently announced its participation in several significant investor conferences this May and June 2026. These events will provide the company an opportunity to discuss its innovative approaches and groundbreaking research that aims to transform the lives of patients with rare diseases.

Key Conferences Scheduled

1. RBC Global Healthcare Conference
Scheduled for May 19, 2026, this event will see Jazz Pharmaceuticals' leadership take part in a fireside chat at 8:00 AM ET. This conference is known for focusing on the intersection of healthcare and investment, where the company representatives are expected to convey insights about their current projects and future directions.

2. TD Cowen 7th Annual Oncology Innovation Summit
On May 27, 2026, Jazz Pharmaceuticals will be featured during this event, commencing at 2:00 PM ET. This summit is particularly significant within the oncology community, and the discussions will likely revolve around the company’s advancements in oncology therapies and their impact on patient care.

3. Jefferies Global Healthcare Conference
The final event in this lineup is set for June 3, 2026, at 10:30 AM ET. The Jefferies Conference is renowned for gathering leaders from various sectors within the healthcare industry, providing a platform for sharing innovative ideas and strategies.

Accessibility of the Events

Audio webcasts of these fireside chats will be made accessible through the Investors section of the Jazz Pharmaceuticals website. Following each live discussion, the webcasts will be archived and available for replay for 30 days, ensuring that all interested parties can gain insights from the events even if they can't tune in live.

About Jazz Pharmaceuticals

Founded and headquartered in Dublin, Ireland, Jazz Pharmaceuticals is dedicated to addressing the needs of patients suffering from rare diseases. The company has a varied portfolio that includes advanced therapies for conditions such as epilepsies, cancers, and sleep disorders. With a strong focus on patient care, Jazz Pharmaceuticals employs a science-driven approach to develop innovative therapeutics that strive to improve the lives of those it serves.

The participation in these conferences demonstrates Jazz Pharmaceuticals' ongoing commitment to engage with the investment community and share its dedication to developing solutions for unmet medical needs. As the company continues to research and innovate, these events will shed light on its ongoing efforts to bring new treatments to market.

For more information about Jazz Pharmaceuticals, their mission, and upcoming events, visit their official website at www.jazzpharmaceuticals.com.

Engagement with investor conferences is just one of the many ways Jazz Pharmaceuticals underscores its goal of transforming healthcare for patients globally. As they continue to unravel the complexities of rare diseases, the insights garnered from these events are anticipated to foster deeper connections between the company and its stakeholders, while promoting awareness of the critical medical advancements underway.